Jupiter Life Line Hospitals Ltd
Incorporated in 2007, Jupiter Life Line Hospitals Limited is a multi-specialty tertiary and quaternary healthcare provider in the Mumbai Metropolitan Area (MMR) and western region of India.[1]
- Market Cap ₹ 9,094 Cr.
- Current Price ₹ 1,387
- High / Low ₹ 1,654 / 977
- Stock P/E 56.4
- Book Value ₹ 190
- Dividend Yield 0.07 %
- ROCE 22.2 %
- ROE 17.8 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Company has delivered good profit growth of 53.0% CAGR over last 5 years
Cons
- Stock is trading at 7.30 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Quarterly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|---|---|
320 | 398 | 463 | 461 | 657 | 787 | 911 | 942 | |
266 | 333 | 380 | 392 | 498 | 583 | 687 | 714 | |
Operating Profit | 54 | 65 | 83 | 69 | 159 | 204 | 223 | 228 |
OPM % | 17% | 16% | 18% | 15% | 24% | 26% | 25% | 24% |
5 | 2 | 2 | 4 | 4 | 11 | 30 | 32 | |
Interest | 16 | 24 | 26 | 28 | 29 | 28 | 19 | 11 |
Depreciation | 20 | 24 | 26 | 27 | 28 | 29 | 31 | 31 |
Profit before tax | 24 | 20 | 33 | 18 | 106 | 159 | 204 | 218 |
Tax % | -25% | 8% | 10% | 5% | 20% | 33% | 25% | |
30 | 18 | 30 | 17 | 85 | 107 | 152 | 162 | |
EPS in Rs | 5.88 | 3.57 | 5.83 | 3.26 | 16.65 | 18.97 | 23.18 | 24.73 |
Dividend Payout % | 8% | 0% | 0% | 0% | 0% | 0% | 4% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 18% |
3 Years: | 25% |
TTM: | 15% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 53% |
3 Years: | 109% |
TTM: | 57% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | 29% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 19% |
3 Years: | 22% |
Last Year: | 18% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|
Equity Capital | 51 | 51 | 51 | 51 | 51 | 57 | 66 |
Reserves | 147 | 162 | 186 | 202 | 276 | 409 | 1,180 |
210 | 252 | 263 | 262 | 322 | 298 | 0 | |
63 | 71 | 94 | 100 | 106 | 123 | 115 | |
Total Liabilities | 470 | 537 | 594 | 615 | 755 | 885 | 1,361 |
379 | 431 | 435 | 426 | 465 | 476 | 477 | |
CWIP | 28 | 12 | 10 | 13 | 14 | 16 | 61 |
Investments | 1 | 2 | 2 | 65 | 71 | 95 | 111 |
63 | 92 | 146 | 109 | 205 | 297 | 711 | |
Total Assets | 470 | 537 | 594 | 615 | 755 | 885 | 1,361 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|
43 | 46 | 75 | 113 | 142 | 184 | 110 | |
-43 | -58 | -43 | -78 | -68 | -130 | -256 | |
1 | 16 | -32 | -23 | 10 | -23 | 311 | |
Net Cash Flow | 1 | 3 | -1 | 12 | 84 | 31 | 164 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|---|---|
Debtor Days | 20 | 24 | 35 | 16 | 15 | 19 | 19 |
Inventory Days | 60 | 46 | 64 | 45 | 38 | 42 | 39 |
Days Payable | 224 | 168 | 268 | 192 | 155 | 169 | 116 |
Cash Conversion Cycle | -144 | -98 | -169 | -132 | -101 | -108 | -59 |
Working Capital Days | 11 | 18 | 44 | 4 | -4 | -16 | -7 |
ROCE % | 10% | 12% | 9% | 23% | 27% | 22% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
1d - Read with SEBI (LODR), Regulations, 2015, please find attached a copy of newspaper publication in the following newspapers with respect to dispatch of Postal Ballot …
-
Shareholder Meeting / Postal Ballot-Notice of Postal Ballot
2d - Postal ballot notice for director appointment approval.
- Closure of Trading Window 25 Sep
-
Intimation Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Change In Designation Of Senior Management Personnel Of The Company
14 Sep - Change in designation of Mr. Sumit Goda to CCO.
-
Intimation Pursuant To Regulation 30 Of SEBI (LODR) Regulations, 2015 - Appointment Of Statutory Auditor Of Material Subsidiary (JHPPL)
6 Sep - Appointment of new statutory auditor for subsidiary.
Concalls
-
Aug 2024Transcript PPT
-
May 2024Transcript PPT
-
Feb 2024Transcript PPT
-
Nov 2023Transcript PPT
-
Oct 2023TranscriptNotesPPT
Business Profile[1] The company has been operating for over 15 years as a corporate quaternary care healthcare service provider in the western regions of India and currently operates three hospitals under the Jupiter brand in Thane, Pune, and Indore. They operate 1194 beds, and have 1,306 doctors including specialists, physicians, and surgeons, as of March 31, 2023.